Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder (2011)
- Autores:
- Autores USP: MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; FOSSALUZA, VICTOR - IME
- Unidades: FM; IME
- DOI: 10.1590/S1807-59322011000300004
- Assuntos: FATORES DE RISCO; TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA); TRANSTORNOS DA ANSIEDADE; TRANSTORNOS SOMATOFORMES
- Idioma: Inglês
- Imprenta:
- Fonte:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
DINIZ, Juliana Belo et al. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder. Clinics, v. 66, n. 3, p. 387-393, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000300004. Acesso em: 25 abr. 2024. -
APA
Diniz, J. B., Malavazzi, D. M., Fossaluza, V., Belotto-Silva, C., Borcato, S., Pimentel, I., et al. (2011). Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder. Clinics, 66( 3), 387-393. doi:10.1590/S1807-59322011000300004 -
NLM
Diniz JB, Malavazzi DM, Fossaluza V, Belotto-Silva C, Borcato S, Pimentel I, Miguel EC, Shavitt RG. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder [Internet]. Clinics. 2011 ; 66( 3): 387-393.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1590/S1807-59322011000300004 -
Vancouver
Diniz JB, Malavazzi DM, Fossaluza V, Belotto-Silva C, Borcato S, Pimentel I, Miguel EC, Shavitt RG. Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder [Internet]. Clinics. 2011 ; 66( 3): 387-393.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1590/S1807-59322011000300004 - Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial
- Comorbid major depression in obsessive-compulsive disorder patients
- Perinatal risk factors and obsessive-compulsive spectrum disorders in patients with rheumatic fever
- Higher prevalence of obsessive-compulsive and related disorders in rheumatic fever
- Does anti-obsessional pharmacotherapy treat so-called comorbid depressive and anxiety states?
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- Validation of the University of Sao Paulo Sensory Phenomena Scale: Initial Psychometric Properties
Informações sobre o DOI: 10.1590/S1807-59322011000300004 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
